This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Emergency contraception (evidence relating to efficacy)

Authoring team

In the UK three forms of emergency contraceptives are currently recommended: (1)

  • A copper intrauterine device (Cu-IUD).
  • An oral progestogen-only emergency contraceptive (POEC) - levonorgestrel (LNG).
  • A selective progesterone receptor modulator (SPRM) - ulipristal acetate (UPA) (3)

The Faculty of Sexual and Reproductive Healthcare (FSRH) guidelines for emergency contraception state: (1)

  • clinicians should advise women that the Cu-IUD is the most effective emergency contraceptive. (1,2)
  • a Cu-IUD can be inserted up to five days after the first UPSI in a natural menstrual cycle, or up to five days after the earliest likely date of ovulation (whichever is later).
  • UPA-EC has been demonstrated to be more effective than LNG-EC.(1,2)
  • the available evidence suggests that an oral emergency contraceptive administered after ovulation is ineffective.

Reference

  1. Clinical Guidance: Emergency Contraception. Faculty of Sexual and Reproductive Healthcare (March 2017 - updated July 2023)
  2. Practice Bulletin No. 152: Emergency Contraception. Obstet Gynecol. 2015 Sep;126(3):e1-e11.
  3. Richardson AR, Maltz FN. Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception. Clin Ther. 2012 Jan;34(1):24-36.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.